Manager, Supply Chain Operations And Planning Jobs in Waltham, MA at ImmunoGen
Title: Manager, Supply Chain Operations And Planning
Location: Waltham, MA
Salary: $100K — $150K *
Category: Pharmaceuticals & Biotech
As the Manager, Supply Chain Operations and Planning you will be in a unique position to have visibility and responsibilities across the entire range of our products from CMO manufacturing to patient delivery and across both the manufacturing and clinical sides of the organization.
Essential Duties and Responsibilities:
Working cross-functionally and with high visibility across the organization, the Manager, Supply Chain Operations and Planning will lead supply chain support of clinical trials for development programs to ensure continuous product availability for patients. In this role, you will proactively identify and resolve potential risks, monitor on-going performance, negotiate production plans, analyze demand inputs, and manage inventory levels. Representing Supply Chain, this role will support critical corporate processes such as Long Range Planning (LRP), Sales & Operations Planning (S&OP), Clinical Study Teams (CST), and Chemistry, Manufacturing and Controls (CMC) teams operations.
Manage all operational supply chain activities for clinical trials including label development and approval, label and pack production scheduling, inventory tracking, IRT forecasting and safety stock levels, and temperature excursion management.
Review clinical trial protocols and understand impact on supply.
Partner with CMC teams and Clinical Operations to identify demand assumptions such as stability, sampling, enrollment rate, number of sites, and number of countries, while ensuring changes to production strategy, trial design, enrollment timelines, manufacturing availability and regulatory requirements are considered.
Monitor Drug Product inventory levels at depots and clinical sites through the life of a trial; take preventive actions to avoid potential supply issues while minimizing product loss to expiry or destruction.
Maintain and improve Excel-based models to ensure sufficient capacity across ImmunoGen’s external manufacturing network
Manage vendor selection, budgeting, procurement and distribution for combination or comparator drugs required for clinical trials.
Coordinate US and international distribution and logistics between CMOs and with third party storage depots.
Lead the S&OP process supporting clinical programs.
Proactively manage the consolidated production schedule, global inventory tracker, and shipment tracker to ensure materials are ordered, received, tested and released in a timely fashion to support the master schedule.
Act as the supply chain representative on multiple technical CMC teams and sub-teams across various products.
Lead process improvement initiatives across the entire supply chain and manage special projects related to commercial launch readiness.
Who You Are
B.S and/or advance degree in Industrial Engineering, Operations Management, Supply Chain Management or a related discipline, M.B.A is a plus
At least 7 years of supply chain experience across a range of functions (i.e. production planning, inventory management, distribution, logistics, project management) in the life sciences industry
Expert at Excel spreadsheets (pivot tables, lookup functions, index, offset, charts); experience building, maintaining, and improving complex planning and tracking tools
International logistics experience and managing within a virtual supply chain is a plus
Solid record of accomplishments building relationships with diverse groups including Ext…
ImmunoGen, Inc. (NASDAQ: IMGN) is a biotechnology company focused on the development of antibody-drug conjugate (ADC) therapeutics for the treatment of cancer. ImmunoGen was founded in 1981 and is headquartered in Waltham, Massachusetts. An ImmunoGen ADC contains a manufactured antibody that binds to a target found on cancer cells, with one of the companys potent cell-killing agents attached as a "payload". The antibody serves to deliver the cell-killing agent specifically to cancer cells bearing its target and the payload serves to kill these cells. In some cases, the antibody also has anticancer activity. The ADCs currently in the clinic with ImmunoGen technology employ one of the companys maytansinoid cell-killing agents, either DM1 or DM4, or one of the companys DNA-acting IGN payloads.